← All trials
NCT06315738
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 19, 2024
- Primary completion
- Jun 30, 2029
- Completion date
- Nov 30, 2029
- First posted
- Mar 18, 2024
- Last posted
- Sep 4, 2024
- Enrollment
- 36
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Noveome BiotherapeuticsLead sponsor
- ParexelCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.